Adams Kendra 4
4 · C4 Therapeutics, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Adams Kendra
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-02-13$3.20/sh−1,863$5,962→ 82,576 total - Award
Common Stock
2025-02-14+87,100→ 169,676 total - Tax Payment
Common Stock
2025-02-14$3.18/sh−4,559$14,498→ 165,117 total - Award
Stock Option (Right to Buy)
2025-02-14+130,600→ 130,600 totalExercise: $3.18Exp: 2035-02-13→ Common Stock (130,600 underlying)
Footnotes (3)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.
- [F2]Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.
- [F3]The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.